Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors

Journal of Ovarian Research

Volumn 3, Issue 1, 2010, Pages

  Penumatsa, Krishna ^a   Edassery, Seby L ^a   Barua, Animesh ^a   Bradaric, Michael J ^a   Luborsky, Judith L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD133 ANTIGEN; HERMES ANTIGEN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STEM CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 78650375203     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-3-28     Document Type: Article

References (58)

1. Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. SL Edassery SV Shatavi JP Kunkel C Hauer C Brucker K Penumatsa Y Yu JA Dias JL Luborsky, Fertil Steril 2010 94 2636 41 10.1016/j.fertnstert.2010.04.012 20522323
2. Common autoantibodies in ovarian cancer (OvCa) and infertility may define biomarkers for OvCa risk. J Luborsky Edassery Seby L. Penumatsa Krishna Bradaric Michael Yu Yi Hellstrom Karl Erik Barua Animesh Bitterman Pincas I Hellstrom, Proceedings of the 101st Annual Meeting of the American Association for Cancer Research, Washington, DC Philadelphia (PA) 2010
3. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. V Vasiliou DW Nebert, Hum Genomics 2005 2 138 143 16004729
4. Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. NE Sladek, J Biochem Mol Toxicol 2003 17 7 23 10.1002/jbt.10057 12616643
5. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. SA Marchitti C Brocker D Stagos V Vasiliou, Expert Opin Drug Metab Toxicol 2008 4 697 720 10.1517/17425255.4.6.697 18611112
6. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. C Visus D Ito A Amoscato M Maciejewska-Franczak A Abdelsalem R Dhir DM Shin VS Donnenberg TL Whiteside AB DeLeo, Cancer Res 2007 67 10538 10545 10.1158/0008-5472.CAN-07-1346 17974998
7. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. S Deng X Yang H Lassus S Liang S Kaur Q Ye C Li LP Wang KF Roby S Orsulic, et al. PLoS One 5 10277 10.1371/journal.pone.0010277 20422001
8. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. EH Huang MJ Hynes T Zhang C Ginestier G Dontu H Appelman JZ Fields MS Wicha BM Boman, Cancer Res 2009 69 3382 3389 10.1158/0008-5472.CAN-08-4418 19336570
9. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. T Li Y Su Y Mei Q Leng B Leng Z Liu SA Stass F Jiang, Lab Invest 90 234 244 10.1038/labinvest.2009.127 20010854
10. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. M Patel L Lu DS Zander L Sreerama D Coco JS Moreb, Lung Cancer 2008 59 340 349 10.1016/j.lungcan.2007.08.033 17920722
11. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. G Duester FA Mic A Molotkov, Chem Biol Interact 2003 143-144 201 210 10.1016/S0009-2797(02)00204-1 12604205
12. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. LM De Luca, FASEB J 1991 5 2924 2933 1661245
13. Response of four human ovarian carcinoma cell lines to all-trans retinoic acid: relationship with induction of differentiation and retinoic acid receptor expression. MJ Caliaro C Marmouget S Guichard P Mazars A Valette A Moisand R Bugat S Jozan, Int J Cancer 1994 56 743 748 10.1002/ijc.2910560522 8314353
14. Retinoids and ovarian cancer. D Zhang WF Holmes S Wu DR Soprano KJ Soprano, J Cell Physiol 2000 185 1 20 10.1002/1097-4652(200010)185:1<1::AID- JCP1 3.0.CO;2-O 10942515
15. Biochemical pathways of retinoid transport, metabolism, and signal transduction. JL Napoli, Clin Immunol Immunopathol 1996 80 52 62 10.1006/clin.1996.0142 8811064
16. all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells. S Aebi R Kroning B Cenni A Sharma D Fink G Los R Weisman SB Howell RD Christen, Clin Cancer Res 1997 3 2033 2038 9815594
17. Can fenretinide protect women against ovarian cancer? G De Palo U Veronesi T Camerini F Formelli G Mascotti C Boni V Fosser M Del Vecchio T Campa A Costa, et al. J Natl Cancer Inst 1995 87 146 147 10.1093/jnci/87.2.146 7707390
18. Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer. D Cvetkovic SJ Williams TC Hamilton, Clin Cancer Res 2003 9 1013 1020 12631600
19. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. SG Kang HW Lim OM Andrisani HE Broxmeyer CH Kim, J Immunol 2007 179 3724 3733 17785809
20. GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity. A Yokota H Takeuchi N Maeda Y Ohoka C Kato SY Song M Iwata, Int Immunol 2009 21 361 377 10.1093/intimm/dxp003 19190084
21. Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages. S Manicassamy B Pulendran, Semin Immunol 2009 21 22 27 10.1016/j.smim.2008.07.007 18778953
22. ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. JS Moreb HV Baker LJ Chang M Amaya MC Lopez B Ostmark W Chou, Mol Cancer 2008 7 87 10.1186/1476-4598-7-87 19025616
23. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay. JS Moreb JR Zucali B Ostmark NA Benson, Cytometry B Clin Cytom 2007 72 281 289 17111384
24. ALDH1 expression correlates with favorable prognosis in ovarian cancers. B Chang G Liu F Xue DG Rosen L Xiao X Wang J Liu, Mod Pathol 2009 22 817 823 19329942
25. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. SY Park HE Lee H Li M Shipitsin R Gelman K Polyak, Clin Cancer Res 16 876 887 10.1158/1078-0432.CCR-09-1532 20103682
26. Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium. L Deng GL Shipley DS Loose-Mitchell GM Stancel R Broaddus JH Pickar PJ Davies, J Clin Endocrinol Metab 2003 88 2157 2163 10.1210/jc.2002-021844 12727970
27. The role of vitamin A in mammalian reproduction and embryonic development. M Clagett-Dame HF DeLuca, Annu Rev Nutr 2002 22 347 381 10.1146/annurev.nutr.22.010402.102745E 12055350
28. Expression of enzymes synthesizing (aldehyde dehydrogenase 1 and reinaldehyde dehydrogenase 2) and metabolizaing (Cyp26) retinoic acid in the mouse female reproductive system. J Vermot V Fraulob P Dolle K Niederreither, Endocrinology 2000 141 3638 3645 10.1210/en.141.10.3638 11014218
29. Function of retinoic acid receptors during embryonic development. M Mark NB Ghyselinck P Chambon, Nucl Recept Signal 2009 7 002 19381305
30. Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. MJ Stewart K Malek DW Crabb, J Investig Med 1996 44 42 46 8689400
31. Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Y Alnouti CD Klaassen, Toxicol Sci 2008 101 51 64 10.1093/toxsci/kfm280 17998271
32. Inflammation and cancer. LM Coussens Z Werb, Nature 2002 420 860 867 10.1038/nature01322 12490959
33. Steroid signalling in human ovarian surface epithelial cells: the response to interleukin-1alpha determined by microarray analysis. MT Rae D Niven A Ross T Forster R Lathe HO Critchley P Ghazal SG Hillier, J Endocrinol 2004 183 19 28 10.1677/joe.1.05754 15525570
34. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer. B Tanner JG Hengstler B Dietrich M Henrich P Steinberg W Weikel R Meinert B Kaina F Oesch PG Knapstein, Gynecol Oncol 1997 65 54 62 10.1006/gyno.1996.4593 9103391
35. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. DA Hess TE Meyerrose L Wirthlin TP Craft PE Herrbrich MH Creer JA Nolta, Blood 2004 104 1648 1655 10.1182/blood-2004-02-0448 15178579
36. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. C Ginestier MH Hur E Charafe-Jauffret F Monville J Dutcher M Brown J Jacquemier P Viens CG Kleer S Liu, et al. Cell Stem Cell 2007 1 555 567 10.1016/j.stem.2007.08.014 18371393
37. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. S Ma KW Chan TK Lee KH Tang JY Wo BJ Zheng XY Guan, Mol Cancer Res 2008 6 1146 1153 10.1158/1541-7786.MCR-08-0035 18644979
38. High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma. WF Cheng CY Huang MC Chang YH Hu YC Chiang YL Chen CY Hsieh CA Chen, Br J Cancer 2009 100 1144 1153 10.1038/sj.bjc.6604964 19293794
39. New stereological methods for counting neurons. MJ West, Neurobiol Aging 1993 14 275 285 10.1016/0197-4580(93)90112-O 8367009
40. The efficiency of systematic sampling in stereology and its prediction. HJ Gundersen EB Jensen, J Microsc 1987 147 229 263 3430576
41. Gene expression profiling of epithelial ovarian tumours correlated with malignant potential. S Warrenfeltz S Pavlik S Datta ET Kraemer B Benigno JF McDonald, Mol Cancer 2004 3 27 10.1186/1476-4598-3-27 15471544
42. Gene expression profiling of human ovarian tumours. S Biade M Marinucci J Schick D Roberts G Workman EH Sage PJ O'Dwyer VA Livolsi SW Johnson, Br J Cancer 2006 95 1092 1100 10.1038/sj.bjc.6603346 16969345
43. Differential gene expression between normal and tumor-derived ovarian epithelial cells. RS Ismail RL Baldwin J Fang D Browning BY Karlan JC Gasson DD Chang, Cancer Res 2000 60 6744 6749 11118061
44. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. AD Santin F Zhan S Bellone M Palmieri S Cane E Bignotti S Anfossi M Gokden D Dunn JJ Roman, et al. Int J Cancer 2004 112 14 25 10.1002/ijc.20408 15305371
45. The effects of dimethyl sulfoxide and retinoic acid on the cell growth and the phenotype of ovarian cancer cells. TW Grunt C Somay M Pavelka A Ellinger E Dittrich C Dittrich, J Cell Sci 1991 100 Pt 3 657 666 1808213
46. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. M Shih Ie RJ Kurman, Am J Pathol 2004 164 1511 1518 15111296
47. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. AK Croker D Goodale J Chu C Postenka BD Hedley DA Hess AL Allan, J Cell Mol Med 2009 13 2236 2252 10.1111/j.1582-4934.2008.00455.x 18681906
48. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. F Jiang Q Qiu A Khanna NW Todd J Deepak L Xing H Wang Z Liu Y Su SA Stass RL Katz, Mol Cancer Res 2009 7 330 338 10.1158/1541-7786.MCR-08-0393 19276181
49. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. JP Chute GG Muramoto J Whitesides M Colvin R Safi NJ Chao DP McDonnell, Proc Natl Acad Sci USA 2006 103 11707 11712 10.1073/pnas.0603806103 16857736
50. Cancer stem cells in solid tumors: elusive or illusive? Y Welte J Adjaye HR Lehrach CR Regenbrecht, Cell Commun Signal 2010 8 6 10.1186/1478-811X-8-6 20459772
51. Is ALDH1 a good method for definition of breast cancer stem cells? V Neumeister D Rimm, Breast Cancer Res Treat 2010 123 109 11 10.1007/s10549-009- 0656-y 19946740
52. Immune physiology and oogenesis in fetal and adult humans, ovarian infertility, and totipotency of adult ovarian stem cells. A Bukovsky MR Caudle I Virant-Klun SK Gupta R Dominguez M Svetlikova F Xu, Birth Defects Res C Embryo Today 2009 87 64 89 10.1002/bdrc.20146 19306350
53. Minireview: stem cell contribution to ovarian development, function, and disease. JL Tilly BR Rueda, Endocrinology 2008 149 4307 4311 10.1210/en.2008-0458 18556344
54. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. PP Szotek R Pieretti-Vanmarcke PT Masiakos DM Dinulescu D Connolly R Foster D Dombkowski F Preffer DT Maclaughlin PK Donahoe, Proc Natl Acad Sci USA 2006 103 11154 11159 10.1073/pnas.0603672103 16849428
55. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. SA Bapat AM Mali CB Koppikar NK Kurrey, Cancer Res 2005 65 3025 3029 15833827
56. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. AB Alvero R Chen HH Fu M Montagna PE Schwartz T Rutherford DA Silasi KD Steffensen M Waldstrom I Visintin G Mor, Cell Cycle 2009 8 158 166 19158483
57. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. S Zhang C Balch MW Chan HC Lai D Matei JM Schilder PS Yan TH Huang KP Nephew, Cancer Res 2008 68 4311 4320 10.1158/0008-5472.CAN-08- 0364 18519691
58. CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer. MD Curley VA Therrien CL Cummings PA Sergent CR Koulouris AM Friel DJ Roberts MV Seiden DT Scadden BR Rueda R Foster, Stem Cells 2009 19816957